Global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis: a prospective cohort study for the CLEARED ConsortiumJasmohan S. Bajaj, Mingqin Lu, Ashok Choudhury et al.|The Lancet. Gastroenterology & hepatology|2023Cited by 33
High inherited risk predicts age-associated increases in fibrosis in patients with MASLDLuis Antonio Díaz, Veeral Ajmera, Cláudia Alves Couto et al.|Journal of Hepatology|2025Cited by 32
Inherited Genetic Risk of Liver Fibrosis in Lean Versus Nonlean Metabolic Dysfunction–Associated Steatotic Liver Disease ( <scp>MASLD</scp> )Kaleb Tesfai, Veeral Ajmera, Luis Antonio Díaz et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 9
FRI-088 Patterns and predictors of postacute discharge location other than home in a global cohort of 3, 678 patients hospitalized with cirrhosisWai‐Kay Seto, Marco Arrese, Qing Xie et al.|Journal of Hepatology|2024Cited by 0
FRI-053 Wide variations in proton pump inhibitor use in hospitalized patients with cirrhosis in a worldwide cohort shows little impact on clinically significant outcomesJasmohan S. Bajaj, Carlos Benítez, Patrick S. Kamath et al.|Journal of Hepatology|2024Cited by 0